Cancer & SURVIVEiT News

SURVIVEiT Books About Cancer For Children

Books About Cancer for Children

April 21, 2021

How do I talk to my child about cancer? Where do I begin? What is ‘too much’? Talking about cancer with your children can be a tough topic to approach.…

New Genetic Signatures Could Advance Leukemia Precision Medicine

August 28, 2020

New Genetic Signatures Could Advance Leukemia Precision Medicine Using next-generation sequencing, researchers have discovered new genetic signatures that could facilitate precision medicine for children with leukemia. By Jessica Kent March…

FDA approves gemtuzumab ozogamicin for CD33-positive AML in pediatric patients

June 16, 2020

FDA approves gemtuzumab ozogamicin for CD33-positive AML in pediatric patients On June 16, 2020, the Food and Drug Administration extended the indication of gemtuzumab ozogamicin (MYLOTARG, Wyeth Pharmaceuticals LLC) for…

FDA approves selumetinib for neurofibromatosis type 1 with symptomatic, inoperable plexiform neurofi

June 2, 2020

FDA approves selumetinib for neurofibromatosis type 1 with symptomatic, inoperable plexiform neurofibromas On April 10, 2020, the Food and Drug Administration approved selumetinib (KOSELUGO, AstraZeneca) for pediatric patients, 2 years…

A Childhood Cancer Survivor Shares Her Story

February 14, 2020

A childhood cancer diagnosis impacts the child, parents and the entire family. This childhood cancer survivor recounts her symptoms and her experience with cancer. What really stands out is how…

Childhood Cancer Awareness & U.S. Trends in Childrens’ Cancer

September 19, 2019

September is childhood cancer awareness month, bringing up many conversations about the types of cancer that affect children and their families. According to the American Childhood Cancer Organization, “In the…

FDA approves longer-acting calaspargase pegol-mknl for ALL

January 15, 2019

On December 20, 2018, the Food and Drug Administration approved calaspargase pegol-mknl (ASPARLAS, Servier Pharmaceuticals LLC), an asparagine specific enzyme, as a component of a multi-agent chemotherapeutic regimen for acute…

Tailored Drug Cocktails Offer Hope to Kids with Aggressive Brain Tumors

September 4, 2018

Tailored Drug Cocktails Offer Hope to Kids with Aggressive Brain Tumors Clinical Trial Tests Personalized Treatments in Push to Improve Pediatric Cancer Survival By Suzanne Leigh on August 29, 2018…